ArticlePloS one2022

Evaluation of metabolic dysfunction-associated fatty liver disease using FibroScan, diet, and microbiota: A large cross-sectional study.

Tetsuyuki Tateda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.